These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 30000068

  • 1.
    ; 2006. PubMed ID: 30000068
    [Abstract] [Full Text] [Related]

  • 2. SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis.
    Storms WW, Bodman SF, Nathan RA, Chervinsky P, Banov CH, Dockhorn RJ, Jarmoszuk I, Zeitz HJ, McGeady SJ, Pinnas JL.
    J Allergy Clin Immunol; 1989 Jun; 83(6):1083-90. PubMed ID: 2471718
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.
    Kaiser HB, Banov CH, Berkowitz RR, Bernstein DI, Bronsky EA, Georgitis JW, Mendelson LM, Rooklin AR, Sholler LJ, Stricker WW, Harrison JE, Danzig MR, Lorber RR.
    Am J Ther; 1998 Jul; 5(4):245-51. PubMed ID: 10099066
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D 24-Hour--original formulation).
    Manda B, Drinkard CR, Shatin D, Graham DJ.
    Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):29-34. PubMed ID: 14971120
    [Abstract] [Full Text] [Related]

  • 7. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
    Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R.
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.
    Bronsky E, Boggs P, Findlay S, Gawchik S, Georgitis J, Mansmann H, Sholler L, Wolfe J, Meltzer E, Morris R.
    J Allergy Clin Immunol; 1995 Aug; 96(2):139-47. PubMed ID: 7636050
    [Abstract] [Full Text] [Related]

  • 9. Development of modified-release dosage forms containing loratadine and pseudoephedrine sulfate.
    Sznitowska M, Cal K, Kupiec K.
    Acta Pol Pharm; 2004 Dec; 61 Suppl():72-4. PubMed ID: 15909946
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males.
    Kosoglou T, Radwanski E, Batra VK, Lim JM, Christopher D, Affrime MB.
    Clin Ther; 1997 Dec; 19(5):1002-12. PubMed ID: 9385487
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; 2006 Dec. PubMed ID: 30000785
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of the efficiency and safety of the loratadine with pseudoephedrine combination drug in treatment of seasonal allergic rhinitis].
    Zawisza E, Lipiec A, Rapiejko P.
    Pol Merkur Lekarski; 1998 Feb; 4(20):66-8. PubMed ID: 9634291
    [Abstract] [Full Text] [Related]

  • 16. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
    Berger WE, Fineman SM, Lieberman P, Miles RM.
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis.
    Prevost M, Turenne Y, Moote DW, Mazza J, Clermont A, PetitClerc C, Danzig MR.
    Clin Ther; 1994 Jun; 16(1):50-6. PubMed ID: 7911402
    [Abstract] [Full Text] [Related]

  • 18. An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model.
    Abelson MB, Welch DL.
    Acta Ophthalmol Scand Suppl; 2000 Jun; (230):60-3. PubMed ID: 11057354
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.